Novartis plans to sell medications for heart disease, diabetes and other non-infectious diseases for just US$1 per month's supply in poor countries.
The experimental Ebola drug ZMapp has been granted fast-track status by the U.S. Food and Drug Administration, which could speed its arrival on the market, the drugmaker said Thursday.
A cancer-killing therapy that engineers a patient's own immune cells to wipe out chronic lymphocytic leukemia (CLL) has shown long-term success in a handful of people, a study said Wednesday.
A small drugmaker in the U.S. may succeed next week where many of the world's largest pharmaceutical companies have failed: in winning approval for the first drug to boost women's sexual desire.
The maker of a prescription fish-oil pill won an early victory Friday against the U.S. Food and Drug Administration (FDA) over its right to publicize unapproved uses of its drug.
A new drug compound could lead to a breakthrough in the fight against bovine spongiform encephalopathy, the incurable brain-wasting disease also known as mad cow disease, researchers said Wednesday.
The U.S. Food and Drug Administration said Tuesday it has approved the first drug made with a 3D printer -- pills for treating epilepsy.
A dengue vaccine candidate by French drugmaker Sanofi protects more than three quarters of participants, an analysis found Monday.
European Union nations have until Aug. 20 to suspend the sale of some 700 generic drugs made in India, the EU's executive confirmed Monday.
Defective or 'leaky' vaccines may lead to even more powerful viruses, according to a study on poultry that raises concerns about vaccine development in humans.